Back to Trades
Hyep Ivan
Chief Financial OfficerCIK 0002034668
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 15
- Companies
- 1
- Active
- 2025–2026
Hyep Ivan, Chief Financial Officer, has filed 10 SEC reports (2025–2026), all concentrated in Bicara Therapeutics Inc. (BCAX), totaling $5.7M in disclosed volume. Weighing $0 bought versus $2.7M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Jul 10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $807.7K |
| May 26 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $187.9K |
| Apr 22 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $211.6K |
| Mar 24 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $170.3K |
| Mar 5 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $301.0K |
| Feb 4 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Award | $2.1M |
| Jan 26 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $34.2K |
| Nov 25 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $341.1K |
| Oct 10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $116.9K |
| Oct 8 | BCAX Bicara Therapeutics Inc. | Hyep Ivan | Chief Financial Officer | Sell | $553.2K |
10 filings